Gert Attard
researcherMale0.0Global Dominance: 0.00%
Prof Gert Attard is a prominent cancer researcher and co-leader of a groundbreaking study at the UCL Cancer Institute, where he has been instrumental in developing an AI test that predicts which men with high-risk prostate cancer will benefit from the drug abiraterone, a treatment that has the potential to halve the risk of death for those identified as likely responders.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Prof Gert Attard, of the UCL Cancer Institute, co-led the study showing how algorithms can tailor treatments for prostate cancer patients.
New AI test can predict which men will benefit from prostate cancer drug | Prostate cancerThe Guardian·
United Kingdom· 2025-05-30
United Kingdom· 2025-05-30
